Maintenance: Wednesday, 22 November 2017, 07:00-08:00
Maintenance work on the ZORA servers is provided. There may be short interruptions in the service between 07:00 and 08:00. Thank you for your patience.
Venalis, P; Maurer, B; Akhmetshina, A; Busch, N; Dees, C; Stürzl, M; Zwerina, J; Jüngel, A; Gay, S; Schett, G; Distler, O; Distler, J H W (2009). Lack of inhibititory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo. Journal of Cellular and Molecular Medicine, 13(10):4185-4191.
Akhmetshina, A; Dees, C; Busch, N; Beer, J; Sarter, K; Zwerina, J; Zimmer, A; Distler, O; Schett, G; Distler, J H W (2009). The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis. Arthritis and Rheumatism, 60(4):1129-1136.
Akhmetshina, A; Venalis, P; Dees, C; Busch, N; Zwerina, J; Schett, G; Distler, O; Distler, J H W (2009). Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis and Rheumatism, 60(1):219-224.
Maurer, B; Busch, N; Jüngel, A; Pileckyte, M; Gay, R E; Michel, B A; Schett, G; Gay, S; Distler, J; Distler, O (2009). Transcription factor Fos-Related Antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation, 120(23):2367-2376.